InChI=1S/C22H32O4/c1- 2- 3- 10- 15- 20(23) 16- 11- 7- 5- 4- 6- 8- 12- 17- 21(24) 18- 13- 9- 14- 19- 22(25) 26/h3,5- 13,16- 17,20- 21,23- 24H,2,4,14- 15,18- 19H2,1H3,(H,25,26) /b7- 5- ,8- 6- ,10- 3- ,13- 9- ,16- 11+,17- 12+/t20- ,21+/m0/s1 |
CFOFZYMMJZILHE-XGTWDWJNSA-N |
CC\C=C/C[C@H](O)\C=C\C=C/C\C=C/C=C/[C@@H](O)C\C=C/CCC(O)=O |
|
Mus musculus
(NCBI:txid10090)
|
See:
PubMed
|
Trypanosoma cruzi
(NCBI:txid5693)
|
See:
PubMed
|
Oncorhynchus mykiss
(NCBI:txid8022)
|
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
PubMed
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
marine xenobiotic metabolite
Any metabolite produced by metabolism of a xenobiotic compound in marine macro- and microorganisms.
animal metabolite
Any eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(4Z,7S,8E,10Z,13Z,15E,17S,19Z)- 7,17- dihydroxydocosa- 4,8,10,13,15,19- hexaenoic acid
|
(4Z,7S,8E,10Z,13Z,15E,17S,19Z)- 7,17- dihydroxydocosahexaenoic acid
|
ChEBI
|
7(S),17(S)-diHDHA
|
ChEBI
|
7(S),17(S)-resolvin D5
|
ChEBI
|
7S,17S-diHDHA
|
ChEBI
|
7S,17S- dihydroxy- 4Z,8E,10Z,13Z,15E,19Z- docosahexaenoic acid
|
ChEBI
|
resolvin-D5
|
ChEBI
|
RvD5
|
ChEBI
|
578008-43-2
|
CAS Registry Number
|
ChEBI
|
|